HUMANA INC (HUM) EBITDA
- 2026-03-31: Basis Reported; EBITDA (m); Operating income $1.75B; Depreciation and amortization (m).
- 2025-09-30: Basis Reported; EBITDA (m); Operating income $400.00M; Depreciation and amortization (m).
- 2025-06-30: Basis Reported; EBITDA (m); Operating income $1.10B; Depreciation and amortization (m).
- 2025-03-31: Basis Reported; EBITDA (m); Operating income $2.01B; Depreciation and amortization (m).
Historical EBITDA
EBITDA 3 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | Reported | (m) | $1.75B | (m) | (m) | (m) | $121.00M | $1.25B | (m) | (m) | $4.02B | $395.00M |
| 2025-09-30 | Reported | (m) | $400.00M | (m) | (m) | (m) | $135.00M* | $971.00M* | (m) | (m) | $4.08B | -$86.00M |
| 2025-06-30 | Reported | (m) | $1.10B | (m) | (m) | (m) | $114.00M* | $1.27B* | (m) | (m) | $3.55B | $179.00M |
| 2025-03-31 | Reported | (m) | $2.01B | (m) | (m) | (m) | $95.00M | $331.00M | (m) | (m) | $3.38B | $406.00M |
| 2024-09-30 | Reported | (m) | $728.00M | (m) | (m) | (m) | $130.00M* | $1.86B* | (m) | (m) | $3.34B | $155.00M |
| 2024-06-30 | Reported | (m) | $1.14B | (m) | (m) | (m) | $114.00M* | $1.21B* | (m) | (m) | $3.15B | $223.00M |
| 2024-03-31 | Reported | (m) | $1.24B | (m) | (m) | (m) | $177.00M | $423.00M | (m) | (m) | $3.04B | $251.00M |
| 2023-09-30 | Reported | (m) | $1.21B | (m) | (m) | (m) | $234.00M* | $1.25B* | (m) | (m) | $3.27B | $256.00M |
| 2023-06-30 | Reported | (m) | $1.44B | (m) | (m) | (m) | $264.00M* | $3.18B* | (m) | (m) | $3.11B | $296.00M |
| 2023-03-31 | Reported | (m) | $1.72B | (m) | (m) | (m) | $223.00M | $6.69B | (m) | (m) | $2.98B | $359.00M |
| 2022-09-30 | Reported | (m) | $1.17B | (m) | (m) | (m) | $288.00M* | $8.45B* | (m) | (m) | $3.06B | $107.00M |
| 2022-06-30 | Reported | (m) | $1.22B | (m) | (m) | (m) | $279.00M* | $959.00M* | (m) | (m) | $3.17B | $427.00M |
| 2022-03-31 | Reported | (m) | $1.29B | (m) | (m) | (m) | $295.00M | $302.00M | (m) | (m) | $2.89B | $286.00M |
| 2021-09-30 | Reported | (m) | $628.00M | (m) | (m) | (m) | $326.00M* | $2.83B* | (m) | (m) | $2.60B | $120.00M |
| 2021-06-30 | Reported | (m) | $1.24B | (m) | (m) | (m) | $329.00M* | $360.00M* | (m) | (m) | $2.12B | $183.00M |
| 2021-03-31 | Reported | (m) | $1.22B | (m) | (m) | (m) | $290.00M | -$837.00M | (m) | (m) | $2.01B | $233.00M |
| 2020-09-30 | Reported | (m) | $1.82B | (m) | (m) | (m) | $250.00M* | $1.81B* | (m) | (m) | $2.51B | $450.00M |
| 2020-06-30 | Reported | (m) | $2.44B | (m) | (m) | (m) | $226.00M* | $3.07B* | (m) | (m) | $2.35B | $783.00M |
| 2020-03-31 | Reported | (m) | $1.07B | (m) | (m) | (m) | $192.00M | $474.00M | (m) | (m) | $2.12B | $252.00M |
| 2019-09-30 | Reported | (m) | $868.00M | (m) | (m) | (m) | $210.00M* | $2.44B* | (m) | (m) | $1.89B | $200.00M |
| 2019-06-30 | Reported | (m) | $1.11B | (m) | (m) | (m) | $157.00M* | $1.43B* | (m) | (m) | $1.70B | $301.00M |
| 2019-03-31 | Reported | (m) | $847.00M | (m) | (m) | (m) | $139.00M | $896.00M | (m) | (m) | $1.66B | $183.00M |
| 2018-09-30 | Reported | (m) | $961.00M | (m) | (m) | (m) | $164.00M* | -$1.05B* | (m) | (m) | $1.90B | $266.00M |
| 2018-06-30 | Reported | (m) | $862.00M | (m) | (m) | (m) | $138.00M* | -$125.00M* | (m) | (m) | $1.76B | -$174.00M |
| 2018-03-31 | Reported | (m) | $760.00M | (m) | (m) | (m) | $134.00M | $3.69B | (m) | (m) | $1.75B | $216.00M |
| 2017-09-30 | Reported | (m) | $858.00M | (m) | (m) | (m) | $143.00M* | $2.86B* | (m) | (m) | $1.69B | $300.00M |
| 2017-06-30 | Reported | (m) | $1.10B | (m) | (m) | (m) | $111.00M* | -$106.00M* | (m) | (m) | $1.45B | $392.00M |
| 2017-03-31 | Reported | (m) | $1.74B | (m) | (m) | (m) | $122.00M | $4.21B | (m) | (m) | $1.55B | $574.00M |
| 2016-09-30 | Reported | (m) | $949.00M | (m) | (m) | (m) | $139.00M* | $4.50B* | (m) | (m) | $1.74B | $452.00M |
| 2016-06-30 | Reported | (m) | $683.00M | (m) | (m) | (m) | $131.00M* | -$296.00M* | (m) | (m) | $1.70B | $325.00M |
| 2016-03-31 | Reported | (m) | $547.00M | (m) | (m) | (m) | $125.00M | $502.00M | (m) | (m) | $1.73B | $246.00M |
| 2015-09-30 | Reported | (m) | $695.00M | (m) | (m) | (m) | $125.00M* | $1.03B* | (m) | (m) | $1.69B | $334.00M |
| 2015-06-30 | Reported | (m) | $573.00M | (m) | (m) | (m) | $136.00M* | -$608.00M* | (m) | (m) | $1.82B | $362.00M |
| 2015-03-31 | Reported | (m) | $790.00M | (m) | (m) | (m) | $123.00M | $107.00M | (m) | (m) | $1.95B | $314.00M |
| 2014-09-30 | Reported | (m) | $589.00M | (m) | (m) | (m) | $145.00M* | $954.00M* | (m) | (m) | $1.90B | $261.00M |
| 2014-06-30 | Reported | (m) | $681.00M | (m) | (m) | (m) | $110.00M* | -$200.00M* | (m) | (m) | $1.83B | $302.00M |
| 2014-03-31 | Reported | (m) | $721.00M | (m) | (m) | (m) | $106.00M | $671.00M | (m) | (m) | $1.78B | $318.00M |
| 2013-09-30 | Reported | (m) | $621.00M | (m) | (m) | (m) | $123.00M* | $1.15B* | (m) | (m) | $1.54B | $218.00M |
| 2013-06-30 | Reported | (m) | $689.00M | (m) | (m) | (m) | $97.00M* | $173.00M* | (m) | (m) | $1.46B | $234.00M |
| 2013-03-31 | Reported | (m) | $765.00M | (m) | (m) | (m) | $90.00M | $412.00M | (m) | (m) | $1.45B | $257.00M |
| 2012-09-30 | Reported | (m) | $701.00M | (m) | (m) | (m) | $119.00M* | -$1.33B* | (m) | (m) | $1.41B | $249.00M |
| 2012-06-30 | Reported | (m) | $590.00M | (m) | (m) | (m) | $99.00M* | $706.00M* | (m) | (m) | $1.38B | $208.00M |
| 2012-03-31 | Reported | (m) | $416.00M | (m) | (m) | (m) | $86.00M | $2.35B | (m) | (m) | $1.38B | $142.00M |
| 2011-09-30 | Reported | (m) | $726.00M | (m) | (m) | (m) | $87.00M* | $2.92B* | (m) | (m) | $1.36B | $254.00M |
| 2011-06-30 | Reported | (m) | $754.00M | (m) | (m) | (m) | $58.00M* | $161.00M* | (m) | (m) | $1.19B | $266.00M |
| 2011-03-31 | Reported | (m) | $524.00M | (m) | (m) | (m) | $71.00M | $796.00M | (m) | (m) | $1.26B | $182.00M |
| 2010-09-30 | Reported | (m) | $648.43M | (m) | (m) | (m) | $61.01M* | $1.21B* | (m) | (m) | $1.00B | $229.07M |
| 2010-06-30 | Reported | (m) | $562.08M | (m) | (m) | (m) | $52.40M* | $325.31M* | (m) | (m) | $1.09B | $195.78M |
| 2010-03-31 | Reported | (m) | $443.24M | (m) | (m) | (m) | $39.03M | $754.65M | (m) | (m) | $1.06B | $158.16M |
| 2009-09-30 | Reported | (m) | $495.61M | (m) | (m) | (m) | $39.53M* | $940.11M* | (m) | (m) | $1.05B | $167.83M |
| 2009-06-30 | Reported | (m) | $466.52M | (m) | (m) | (m) | $43.55M* | $161.86M* | (m) | (m) | $1.00B | $158.17M |
| 2009-03-31 | Reported | (m) | $320.53M | (m) | (m) | (m) | $39.05M | $45.52M | (m) | (m) | $1.06B | $88.05M |
| 2008-09-30 | Reported | (m) | $302.21M | (m) | (m) | (m) | $67.50M* | $577.27M* | (m) | (m) | $979.22M | $99.85M |
| 2008-06-30 | Reported | (m) | $342.88M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $916.04M | $115.12M |
EBITDA 12 month
| Date | Basis | EBITDA | Operating income | Depreciation and amortization | Revenue | EBITDA margin | Capital spending | Operating cash flow | Cost of products and services | Research and development | Selling, general and administration | Income tax expense / benefit |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | Reported | (m) | $2.70B | (m) | (m) | (m) | $546.00M | $921.00M | (m) | (m) | $15.45B | $250.00M |
| 2024-12-31 | Reported | (m) | $2.56B | (m) | (m) | (m) | $575.00M | $2.97B | (m) | (m) | $13.70B | $413.00M |
| 2023-12-31 | Reported | (m) | $4.01B | (m) | (m) | (m) | $1.00B | $3.98B | (m) | (m) | $13.19B | $836.00M |
| 2022-12-31 | Reported | (m) | $3.80B | (m) | (m) | (m) | $1.14B | $4.59B | (m) | (m) | $12.67B | $762.00M |
| 2021-12-31 | Reported | (m) | $3.15B | (m) | (m) | (m) | $1.34B | $2.26B | (m) | (m) | $10.12B | $485.00M |
| 2020-12-31 | Reported | (m) | $4.99B | (m) | (m) | (m) | $964.00M | $5.64B | (m) | (m) | $10.05B | $1.31B |
| 2019-12-31 | Reported | (m) | $3.19B | (m) | (m) | (m) | $736.00M | $5.28B | (m) | (m) | $7.38B | $763.00M |
| 2018-12-31 | Reported | (m) | $3.10B | (m) | (m) | (m) | $612.00M | $2.17B | (m) | (m) | $7.53B | $391.00M |
| 2017-12-31 | Reported | (m) | $4.26B | (m) | (m) | (m) | $524.00M | $4.05B | (m) | (m) | $6.57B | $1.57B |
| 2016-12-31 | Reported | (m) | $1.74B | (m) | (m) | (m) | $527.00M | $1.94B | (m) | (m) | $7.17B | $938.00M |
| 2015-12-31 | Reported | (m) | $2.35B | (m) | (m) | (m) | $523.00M | $868.00M | (m) | (m) | $7.29B | $1.16B |
| 2014-12-31 | Reported | (m) | $2.36B | (m) | (m) | (m) | $528.00M | $1.62B | (m) | (m) | $7.64B | $1.02B |
| 2013-12-31 | Reported | (m) | $2.06B | (m) | (m) | (m) | $441.00M | $1.72B | (m) | (m) | $6.36B | $690.00M |
| 2012-12-31 | Reported | (m) | $2.02B | (m) | (m) | (m) | $410.00M | $1.92B | (m) | (m) | $5.83B | $689.00M |
| 2011-12-31 | Reported | (m) | $2.34B | (m) | (m) | (m) | $346.00M | $2.08B | (m) | (m) | $5.39B | $816.00M |
| 2010-12-31 | Reported | (m) | $1.85B | (m) | (m) | (m) | $222.00M | $2.24B | (m) | (m) | $4.38B | $650.00M |
| 2009-12-31 | Reported | (m) | $1.71B | (m) | (m) | (m) | $185.00M | $1.42B | (m) | (m) | $4.01B | $562.00M |
| 2008-12-31 | Reported | (m) | $1.07B | (m) | (m) | (m) | $261.57M | $982.31M | (m) | (m) | $3.74B | $345.69M |
| 2007-12-31 | Reported | (m) | $1.36B | (m) | (m) | (m) | $239.24M | $1.22B | (m) | (m) | $3.48B | $455.62M |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Elevance Health, Inc. (ELV) | United States | $86.364B | 16.90 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |